Similar articles for PMID: 33109586

Year	Number of Results
1998	1
2000	3
2001	1
2002	1
2003	5
2004	6
2005	8
2006	8
2007	7
2008	1
2010	3
2011	6
2012	6
2013	4
2014	6
2015	5
2016	7
2017	1
2018	8
2019	4
2020	4
2021	2
2022	1
2023	1
2024	0

1

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial.

Mitsuya K, Akiyama Y, Iizuka A, Miyata H, Deguchi S, Hayashi N, Maeda C, Kondou R, Kanematsu A, Watanabe K, Ashizawa T, Abe Y, Ito I, Oishi T, Sugino T, Nakasu Y, Yamaguchi K. Mitsuya K, et al. Anticancer Res. 2020 Nov;40(11):6473-6484. doi: 10.21873/anticanres.14669. Anticancer Res. 2020. PMID: 33109586 Clinical Trial.

2

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

Akiyama Y, Oshita C, Kume A, Iizuka A, Miyata H, Komiyama M, Ashizawa T, Yagoto M, Abe Y, Mitsuya K, Watanabe R, Sugino T, Yamaguchi K, Nakasu Y. Akiyama Y, et al. BMC Cancer. 2012 Dec 27;12:623. doi: 10.1186/1471-2407-12-623. BMC Cancer. 2012. PMID: 23270484 Free PMC article. Clinical Trial.

3

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK, Zeh H, Holtzman MP, Reinhart TA, Whiteside TL, Butterfield LH, Hamilton RL, Potter DM, Pollack IF, Salazar AM, Lieberman FS. Okada H, et al. J Clin Oncol. 2011 Jan 20;29(3):330-6. doi: 10.1200/JCO.2010.30.7744. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149657 Free PMC article. Clinical Trial.

4

Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele.

Iwami K, Shimato S, Ohno M, Okada H, Nakahara N, Sato Y, Yoshida J, Suzuki S, Nishikawa H, Shiku H, Natsume A, Wakabayashi T. Iwami K, et al. Cytotherapy. 2012 Jul;14(6):733-42. doi: 10.3109/14653249.2012.666633. Epub 2012 Mar 16. Cytotherapy. 2012. PMID: 22424217 Clinical Trial.

5

A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.

Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H. Tsuboi A, et al. Cancer Immunol Immunother. 2019 Feb;68(2):331-340. doi: 10.1007/s00262-018-2274-1. Epub 2018 Nov 14. Cancer Immunol Immunother. 2019. PMID: 30430205 Free PMC article. Clinical Trial.

6

Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.

Sakai K, Shimodaira S, Maejima S, Udagawa N, Sano K, Higuchi Y, Koya T, Ochiai T, Koide M, Uehara S, Nakamura M, Sugiyama H, Yonemitsu Y, Okamoto M, Hongo K. Sakai K, et al. J Neurosurg. 2015 Oct;123(4):989-97. doi: 10.3171/2015.1.JNS141554. Epub 2015 Aug 7. J Neurosurg. 2015. PMID: 26252465 Clinical Trial.

7

Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma.

Onishi H, Morisaki T, Baba E, Nakamura M, Inaba S, Kuroki H, Matsumoto K, Katano M. Onishi H, et al. Anticancer Res. 2011 Nov;31(11):3995-4005. Anticancer Res. 2011. PMID: 22110233

8

Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.

Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM. Trepiakas R, et al. Vaccine. 2008 Jun 2;26(23):2824-32. doi: 10.1016/j.vaccine.2008.03.054. Epub 2008 Apr 11. Vaccine. 2008. PMID: 18450338

9

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.

Escobar A, López M, Serrano A, Ramirez M, Pérez C, Aguirre A, González R, Alfaro J, Larrondo M, Fodor M, Ferrada C, Salazar-Onfray F. Escobar A, et al. Clin Exp Immunol. 2005 Dec;142(3):555-68. doi: 10.1111/j.1365-2249.2005.02948.x. Clin Exp Immunol. 2005. PMID: 16297169 Free PMC article. Clinical Trial.

10

Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.

Lasky JL 3rd, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Lasky JL 3rd, et al. Anticancer Res. 2013 May;33(5):2047-56. Anticancer Res. 2013. PMID: 23645755 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year